NCT03170895
- Conditions
- AML, FLT3-ITD Mutation, Hematologic Diseases, +6 more
- Locations
-
- The University of Hong Kong Hong Kong
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,110 public trials
619 recruiting studies
Leukemia, Myeloid trial results
NCT02212561
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- University of Chicago Chicago, Illinois, United States
- Duke University Medical Center Durham, North Carolina, United States
NCT01010217
- Conditions
- Anemia, Anemia, Aplastic, Blood Protein Disorders, +38 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT04321161
- Conditions
- Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Medical Center University of Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
NCT02252107
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Liège Liège, Belgium
- University Medical Center Groningen (UMCG) Groningen, Netherlands
- Radboud university medical center Nijmegen, Netherlands
NCT02011945
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- Winship Cancer Institute Atlanta, Georgia, United States
- Dana Farber Cancer Institute. Boston, Massachusetts, United States
- Ut Southwestern Medical Center At Dallas Dallas, Texas, United States
- The University Of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00509093
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Duke University Medical Center Durham, North Carolina, United States
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
NCT02921061
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02416908
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT02892318
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- City of Hope Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- The NewYork-Presbyterian Hospital Columbia University Medical Center New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States